Viruses and microRNA, and HIV/AIDS treatment and prevention in Malawi were the topics of the opening session last night at CROI, the world’s premier scientific conference on HIV.
“The epidemic at 30″ will the focus of the closing plenary on Wednesday in Boston, in the US.
Pre-prophylaxis exposure (PrEP) – in particular HIV-negative people taking tablets to avoid infection – drug resistance, novel antibodies and HIV’s interaction with TB, herpes and opportunistic infections also featured on the programme.
CROI is more focused on science, like immunology, virology and molecular research, than other popular HIV conferences like the biennial International AIDS meetings.
As the latest webcasts and podcasts show, the frontiers of laboratory science and therapeutic approaches are advancing and providing new insights into the prevention and treatment of HIV/AIDS.
But it’s difficult even to decipher the content of sessions, like those under the theme “New Findings and Controversies“, for non-scientists like myself.
At least the South African researchers attending CROI 2011 are likely to report on how these findings impact on their work at the 5th SA AIDS Conference, to be held from 7 to 10 June in Durban.